文章预览
各领域专家汇聚在BioSpark Monthly News论坛，交流过去一个月发生的 生物医药领域大事件 。 本月热点 TOPICS 1. 2024 ASCO updates and beyond 2 . Oncology: DLL3/CD3 BITE approval for the extensive-stage SCLC; Summit/Akeso’s PD-1/VEGF Ivonescimab vs. Keytruda in Phase 3 1L NSCLC; Arvinas’ ER degrader vepdegestrant plus Pfizer’s palbociclib in breast cancer; 3 . Autoimmune Diseases : J acquired Proteologix for $850M and paid Numab $1.25B for atopic dermatitis; Biogen to acquire HI-Bio for $1.8B; GSK’s anti-IL-5 depemokimab succeeded in phase 3 severe asthma; 4 . Other Diseases & New Modalities: Merck to acquire EyeBio for its unique Norrik mimic program; Novo Nordisk’s Factor VIII mimetic bispecific antibody in phase 3 hemophilia A; News on JNJ neuroscience spinout Rapport; Positive clinic data from Dyne for myotonic dystrophy and Duchenne muscular dystroph. 活动详情 主题： Monthly biotech news discussion -May 2024
………………………………
